To validate our findings, we treated the GBM cell line U251 with TMZ chemotherapy in combination with mTOR inhibition, inducing drug-tolerant persisters (Figure 4C,D), in a manner similar to the methods used in our previous study [25]. This evidence concerns the gene MTOR and glioblastoma.